At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
Achondroplasia, the most common form of genetic dwarfism, has historically relied on treatment approaches that require f...
Cold storage infrastructure plays a critical role across the life sciences industry, safeguarding vaccin...
In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...
Cell and gene therapies are transforming the therapeutic landscape, offering the potential to treat prev...
As global life sciences companies seek locations that combine skilled talent, scalable infrastructure, a...
Offering scalable quality grades from Research to GMP, PlasmidFactory supports advanced gene-based innovations worldwide...
ADCs are highly complex molecules that were initially developed to allow highly potent cytotoxic agents to be selectivel...
What strategic gaps in the Korean diagnostics market does this exclusive distribution agreement with Lucent Diagnostics ...
You joined Roche Malaysia in 2021. What have been some of your key priorities over the past couple of years for your clu...
How is Miltenyi Biotec adapting its long-term strategy to meet the specific scientific and clinical demands of ASEAN mar...
What barriers did you face in reaching leadership, and how did you overcome them?Before joining Samsung Bioepis, most of...
Looking back on your career, what were the most significant barriers you faced in reaching leadership roles, and how did...
According to reports, the Asia Pacific (APAC) region is facing a significant challenge with cancer rates, particularly b...
As governments, healthcare providers, and industry stakeholders respond to the increased threat perception of HPV, the c...
In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...
Glutamate-Glutamate-Methionine-Glutamine-Arginine-Arginine-Alanine-Aspartate-NHâ‚‚, has emerged as a notable synthe...
What was the scientific moment or data point that convinced you NK cell–derived extracellular vesicles could becom...
Why does TAXIS choose to focus on antimicrobial resistance? What are the key developments taking place at TAXIS to comba...
Singapore has one of the most advanced biotechnology industries. Singapore began building its biomedical sciences ecosys...
Life sciences M&A accelerated in 2025, with deal sizes increasing and total spend surpassing 2024 levels before the ...
How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...
Significant strides have been made in the detection and treatment of cancer in the last two decades. However, while surv...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
